A Survey on Quantitative
Claims in Direct-to-Consumer Prescription Drug Advertising
No
material or nonsubstantive change to a currently approved
collection
No
Regular
12/02/2024
Requested
Previously Approved
06/30/2027
06/30/2027
4,493
2,993
1,250
1,094
0
0
This survey collects insights on
consumer understanding of quantitative claims in direct-to-consumer
(DTC) prescription drug advertising. It will build on previous
qualitative research by recruiting a wider range of respondents and
weighting the data to make it nationally representative. We plan to
use an address-based mixed-mode methodology that will direct one
randomly chosen member of sampled households to complete a
20-minute online survey, with non-respondents receiving a paper
questionnaire. We will also conduct a within-survey experiment to
test whether a post-paid incentive increases survey
response.
We anticipated 1,100
participants would respond to the survey from our initial
recruitment of 2,993 individuals. However, the response rate was
lower than expected due to declining survey response rates seen
across Federal surveys, resulting in 480 survey responses. The
purpose of this change is to increase the number of respondents to
get closer to the previously estimated survey response and
therefore increase the power to detect differences among subgroups.
We request an additional recruitment of 1,500 individuals, with the
intent to yield an additional 214 completed surveys and allow us to
detect differences of 14.4 percentage points. Based on the initial
recruitment, we are assuming a 15 percent response rate and a 5
percent postage non-deliverable rate for the additional
sample.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.